245 related articles for article (PubMed ID: 32635232)
1. New Insights into Immunological Involvement in Congenital Disorders of Glycosylation (CDG) from a People-Centric Approach.
Francisco R; Pascoal C; Marques-da-Silva D; Brasil S; Pimentel-Santos FM; Altassan R; Jaeken J; Grosso AR; Dos Reis Ferreira V; Videira PA
J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32635232
[TBL] [Abstract][Full Text] [Related]
2. Patient reported outcomes for phosphomannomutase 2 congenital disorder of glycosylation (PMM2-CDG): listening to what matters for the patients and health professionals.
Pascoal C; Ferreira I; Teixeira C; Almeida E; Slade A; Brasil S; Francisco R; Ligezka AN; Morava E; Plotkin H; Jaeken J; Videira PA; Barros L; Dos Reis Ferreira V
Orphanet J Rare Dis; 2022 Oct; 17(1):398. PubMed ID: 36309700
[TBL] [Abstract][Full Text] [Related]
3. Revisiting the immunopathology of congenital disorders of glycosylation: an updated review.
Pascoal C; Francisco R; Mexia P; Pereira BL; Granjo P; Coelho H; Barbosa M; Dos Reis Ferreira V; Videira PA
Front Immunol; 2024; 15():1350101. PubMed ID: 38550576
[TBL] [Abstract][Full Text] [Related]
4. Cardiomyopathy, an uncommon phenotype of congenital disorders of glycosylation: Recommendations for baseline screening and follow-up evaluation.
Zemet R; Hope KD; Edmondson AC; Shah R; Patino M; Yesso AM; Berger JH; Sarafoglou K; Larson A; Lam C; Morava E; Scaglia F
Mol Genet Metab; 2024 Jun; 142(4):108513. PubMed ID: 38917675
[TBL] [Abstract][Full Text] [Related]
5. Renal involvement in PMM2-CDG, a mini-review.
Altassan R; Witters P; Saifudeen Z; Quelhas D; Jaeken J; Levtchenko E; Cassiman D; Morava E
Mol Genet Metab; 2018 Mar; 123(3):292-296. PubMed ID: 29229467
[TBL] [Abstract][Full Text] [Related]
6. Patient-reported outcomes and quality of life in PMM2-CDG.
Ligezka AN; Mohamed A; Pascoal C; Ferreira VDR; Boyer S; Lam C; Edmondson A; Krzysciak W; Golebiowski R; Perez-Ortiz J; Morava E
Mol Genet Metab; 2022 Jun; 136(2):145-151. PubMed ID: 35491370
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Cell Models to Study Monocyte Functions in PMM2 Congenital Disorders of Glycosylation.
de Haas P; de Jonge MI; Koenen HJPM; Joosten B; Janssen MCH; de Boer L; Hendriks WJAJ; Lefeber DJ; Cambi A
Front Immunol; 2022; 13():869031. PubMed ID: 35603178
[TBL] [Abstract][Full Text] [Related]
8. Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literature.
Schiff M; Roda C; Monin ML; Arion A; Barth M; Bednarek N; Bidet M; Bloch C; Boddaert N; Borgel D; Brassier A; Brice A; Bruneel A; Buissonnière R; Chabrol B; Chevalier MC; Cormier-Daire V; De Barace C; De Maistre E; De Saint-Martin A; Dorison N; Drouin-Garraud V; Dupré T; Echenne B; Edery P; Feillet F; Fontan I; Francannet C; Labarthe F; Gitiaux C; Héron D; Hully M; Lamoureux S; Martin-Coignard D; Mignot C; Morin G; Pascreau T; Pincemaille O; Polak M; Roubertie A; Thauvin-Robinet C; Toutain A; Viot G; Vuillaumier-Barrot S; Seta N; De Lonlay P
J Med Genet; 2017 Dec; 54(12):843-851. PubMed ID: 28954837
[TBL] [Abstract][Full Text] [Related]
9. The road to successful people-centric research in rare diseases: the web-based case study of the Immunology and Congenital Disorders of Glycosylation questionnaire (ImmunoCDGQ).
Francisco R; Brasil S; Pascoal C; Jaeken J; Liddle M; Videira PA; Dos Reis Ferreira V
Orphanet J Rare Dis; 2022 Mar; 17(1):134. PubMed ID: 35331276
[TBL] [Abstract][Full Text] [Related]
10. International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, treatment and follow up.
Altassan R; Péanne R; Jaeken J; Barone R; Bidet M; Borgel D; Brasil S; Cassiman D; Cechova A; Coman D; Corral J; Correia J; de la Morena-Barrio ME; de Lonlay P; Dos Reis V; Ferreira CR; Fiumara A; Francisco R; Freeze H; Funke S; Gardeitchik T; Gert M; Girad M; Giros M; Grünewald S; Hernández-Caselles T; Honzik T; Hutter M; Krasnewich D; Lam C; Lee J; Lefeber D; Marques-de-Silva D; Martinez AF; Moravej H; Õunap K; Pascoal C; Pascreau T; Patterson M; Quelhas D; Raymond K; Sarkhail P; Schiff M; Seroczyńska M; Serrano M; Seta N; Sykut-Cegielska J; Thiel C; Tort F; Vals MA; Videira P; Witters P; Zeevaert R; Morava E
J Inherit Metab Dis; 2019 Jan; 42(1):5-28. PubMed ID: 30740725
[TBL] [Abstract][Full Text] [Related]
11. Initial diagnosis of the congenital disorder of glycosylation PMM2-CDG (CDG1a) in a 4-year-old girl after neurosurgical intervention for cerebral hemorrhage.
Stefanits H; Konstantopoulou V; Kuess M; Milenkovic I; Matula C
J Neurosurg Pediatr; 2014 Nov; 14(5):546-9. PubMed ID: 25192236
[TBL] [Abstract][Full Text] [Related]
12. Natural Killer Cell Receptors and Cytotoxic Activity in Phosphomannomutase 2 Deficiency (PMM2-CDG).
García-López R; de la Morena-Barrio ME; Alsina L; Pérez-Dueñas B; Jaeken J; Serrano M; Casado M; Hernández-Caselles T
PLoS One; 2016; 11(7):e0158863. PubMed ID: 27415628
[TBL] [Abstract][Full Text] [Related]
13. AZATAX: Acetazolamide safety and efficacy in cerebellar syndrome in PMM2 congenital disorder of glycosylation (PMM2-CDG).
Martínez-Monseny AF; Bolasell M; Callejón-Póo L; Cuadras D; Freniche V; Itzep DC; Gassiot S; Arango P; Casas-Alba D; de la Morena E; Corral J; Montero R; Pérez-Cerdá C; Pérez B; Artuch R; Jaeken J; Serrano M;
Ann Neurol; 2019 May; 85(5):740-751. PubMed ID: 30873657
[TBL] [Abstract][Full Text] [Related]
14. Congenital disorder of glycosylation - one size does not fit all: a parent's perspective.
Feinberg K
Ther Adv Rare Dis; 2022; 3():26330040221118099. PubMed ID: 37180418
[TBL] [Abstract][Full Text] [Related]
15. PMM2-CDG caused by uniparental disomy: Case report and literature review.
Vaes L; Tiller GE; Pérez B; Boyer SW; Berry SA; Sarafoglou K; Morava E
JIMD Rep; 2020 Jul; 54(1):16-21. PubMed ID: 32685345
[TBL] [Abstract][Full Text] [Related]
16. The Prevalence of PMM2-CDG in Estonia Based on Population Carrier Frequencies and Diagnosed Patients.
Vals MA; Pajusalu S; Kals M; Mägi R; Õunap K
JIMD Rep; 2018; 39():13-17. PubMed ID: 28685491
[TBL] [Abstract][Full Text] [Related]
17. A Participatory Framework for Plain Language Clinical Management Guideline Development.
Francisco R; Alves S; Gomes C; Granjo P; Pascoal C; Brasil S; Neves A; Santos I; Miller A; Krasnewich D; Morava E; Lam C; Jaeken J; Videira PA; Dos Reis Ferreira V
Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36294089
[TBL] [Abstract][Full Text] [Related]
18. An Electronic Questionnaire for Liver Assessment in Congenital Disorders of Glycosylation (LeQCDG): A Patient-Centered Study.
Marques-da-Silva D; Francisco R; Dos Reis Ferreira V; Forbat L; Lagoa R; Videira PA; Witters P; Jaeken J; Cassiman D
JIMD Rep; 2019; 44():55-64. PubMed ID: 30008170
[TBL] [Abstract][Full Text] [Related]
19. Stroke-Like Episodes and Cerebellar Syndrome in Phosphomannomutase Deficiency (PMM2-CDG): Evidence for Hypoglycosylation-Driven Channelopathy.
Izquierdo-Serra M; Martínez-Monseny AF; López L; Carrillo-García J; Edo A; Ortigoza-Escobar JD; García Ó; Cancho-Candela R; Carrasco-Marina ML; Gutiérrez-Solana LG; Cuadras D; Muchart J; Montero R; Artuch R; Pérez-Cerdá C; Pérez B; Pérez-Dueñas B; Macaya A; Fernández-Fernández JM; Serrano M
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29470411
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of platelet N-glycoproteins in PMM2-CDG patients.
de la Morena-Barrio ME; Di Michele M; Lozano ML; Rivera J; Pérez-Dueñas B; Altisent C; Sevivas T; Vicente V; Jaeken J; Freson K; Corral J
Thromb Res; 2014 Mar; 133(3):412-7. PubMed ID: 24388574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
